PDF herunterladen
Endoscopy 2014; 46(04): 306-309
DOI: 10.1055/s-0034-1365392
Endoscopy essentials
© Georg Thieme Verlag KG Stuttgart · New York

Reflux and Barrett’s disease

Oliver Pech
Department of Gastroenterology and interventional Endoscopy, Krankenhaus Barmherzige Brüder Regensburg, Regensburg, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
11. März 2014 (online)

Auch verfügbar auf
    Lizenzen und Reprints
Endoscopy Essentials

Reviews in the Endoscopy Essentials series cite publications from the past year which, in the authors’ opinion, reflect the state-of-the-art in endoscopy. Alongside a short summary of each paper, authors explain why they consider their selected articles to be of importance.

 

  • References

  • 1 Ganz RA, Peters JH, Horgan S et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med 2013; 368: 719-727
    CrossrefPubMedGoogle Scholar
  • 2 Galmiche JP, Hatlebakk J, Attwood S et al. LOTUS Trial Collaborators. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 2011; 305: 1969-1977
    CrossrefPubMedGoogle Scholar
  • 3 Longcroft-Wheaton G, Brown J, Basford P et al. Duration of acetowhitening as a novel objective tool for diagnosing high risk neoplasia in Barrett’s esophagus: a prospective cohort trial. Endoscopy 2013; 45: 426-432
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 4 Guelrud M, Herrera I. Acetic acid improves identification of remnant islands of Barrett’s epithelium after endoscopic therapy. Gastrointest Endosc 1998; 47: 512-515
    CrossrefPubMedGoogle Scholar
  • 5 Pohl J, Pech O, May A et al. Incidence of macroscopically occult neoplasias in Barrett’s esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging?. Am J Gastroenterol 2010; 105: 2350-2356
    CrossrefPubMedGoogle Scholar
  • 6 Phoa KN, Pouw RE, van Vilsteren FG et al. Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 2013; 145: 96-104
    CrossrefPubMedGoogle Scholar
  • 7 Pech O, Behrens A, May AD et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 2008; 57: 1200-1206
    CrossrefPubMedGoogle Scholar
  • 8 Manner H, Rabenstein T, Pech O et al. Ablation of residual Barrett’s epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study). Endoscopy 2014; 46: 6-12
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Shaheen NJ, Overholt BF, Sampliner RE et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology 2011; 141: 460-468
    CrossrefPubMedGoogle Scholar
  • 10 Gupta M, Iyer PG, Lutzke L et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US multicenter consortium. Gastroenterology 2013; 145: 79-86
    CrossrefPubMedGoogle Scholar
  • 11 Pech O, May A, Manner H et al. Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 2014; 146: 652-660
    CrossrefPubMedGoogle Scholar